Key result
COVID-19 pandemic linked to ~25% lower cost-related medication non-adherence among high-risk Medicare patients.
Why the study?
To evaluate cost-related medication non-adherence for a 30-month period before and during the COVID-19 pandemic in Medicare patients at high risk of hospitalization.
Does the COVID-19 pandemic period alter the prevalence and persistence of cost-related medication non-adherence in high-risk Medicare patients compared to the pre-pandemic period?
Cohort (n=677)
No
Does the COVID-19 pandemic period alter the prevalence and persistence of cost-related medication non-adherence in high-risk Medicare patients compared to the pre-pandemic period?
Effect estimate: OR 0.75 (95% CI 0.62-0.91)
Absolute Event Rate: 25.7% vs 31.1%
p-value: p=<0.01
Cost-related medication non-adherence significantly decreased during the COVID-19 pandemic among high-risk Medicare patients, potentially reflecting the protective impact of government economic relief policies.
May indicate protective effects of relief policies on CRN; hypothesis-generating and should not yet change practice.
OBJECTIVE: To study cost-related medication non-adherence (CRN) for a 30-month period before and during the COVID-19 pandemic using a sample of Medicare patients at high risk of hospitalization. DESIGN: A novel data set of quarterly surveys of CRN was used to evaluate CRN before and during the COVID-19 pandemic. Generalized Estimating Equation (GEE) analyses were conducted to evaluate the adjusted coefficients of change in CRN behaviors controlling for socio-demographic and health characteristics. PARTICIPANTS: Six hundred seventy-seven Medicare beneficiaries at high risk of hospitalization who were alive on January 1, 2020 and followed up through quarterly surveys on CRN for 30 months before and during the COVID-19 pandemic. MAIN OUTCOMES AND MEASURES: Two metrics of prevalence and persistence of CRN and their adjusted coefficients in GEE with binomial family distribution and log link function controlling for socio-demographic and health characteristics. RESULTS: A total of 5,990 quarterly surveys were completed by the 677 patients during the 30-month study period. Among the 677 patients, 250 (37%) were men, 591 (87%) were African American, and 288 (42%) were Medicare-Medicaid dual eligible. The unadjusted prevalence of CRN before and during the COVID-19 pandemic was 31.1% and 25.7% respectively (p = 0.02 by Chi-squared test), and persistent CRN rates were 12.1% and 9.7% respectively (p = 0.17 by Chi-squared test). The adjusted odds ratio of CRN prevalence during the pandemic compared to the pre-pandemic level was 0.75 (p<0.01), and 0.74 (p = 0.03) for persistent CRN in GEE estimations. CONCLUSION AND RELEVANCE: There are coherent evidence of a reversal of CRN rates during the COVID-19 pandemic among this high-need, high-cost resource utilization Medicare population. Patients' CRN behaviors may be responsive to exogenous impacts, and the behaviors changed in the same direction with similar magnitude in terms of prevalence (the extensive margin) and persistence (the intensive margin). More research is needed to advance the understanding of the driving forces behind patients' behavioral changes and to identify factors that may be informative for reducing CRN in the long run.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2023) conducted a cohort in Medicare patients at high risk of hospitalization (n=677). COVID-19 pandemic period vs. Pre-pandemic period was evaluated on Prevalence of cost-related medication non-adherence (CRN) (OR 0.75, 95% CI 0.62-0.91, p=<0.01). The COVID-19 pandemic was associated with a significant decrease in the prevalence of cost-related medication non-adherence from 31.1% to 25.7% (adjusted OR 0.75) among high-risk Medicare patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: